Biogen Inc. buy Wells Fargo & Company
Start price
07.08.23
/
50%
€244.00
Target price
07.08.24
€311.86
Performance (%)
-22.77%
Price
02.08.24
€188.45
This prediction will end soon
Summary
This prediction is currently active. The prediction for Biogen Inc. disappoints with a performance of -22.77%. This prediction currently runs until 07.08.24. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Biogen Inc. | -3.086% | -3.086% |
iShares Core DAX® | -3.935% | -2.628% |
iShares Nasdaq 100 | -3.608% | -9.283% |
iShares Nikkei 225® | -4.513% | -6.951% |
iShares S&P 500 | -2.607% | -4.402% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at Wells Fargo & Company from $350.00 to $343.00. They now have an "overweight" rating on the stock.
Ratings data for BIIB provided by MarketBeat